Anorectal Abscess and Fistula-in-Ano: Evidence-Based Management

https://doi.org/10.1016/j.suc.2009.10.001Get rights and content

Section snippets

Pathophysiology

Anorectal abscess occurs commonly in normal, healthy individuals. The most widely recognized cause is described in the cryptoglandular theory, which suggests that an anal crypt gland becomes obstructed with inspissated debris and leads to infection. These glands penetrate the anal sphincter complex to varying degrees, and the suppuration tends to follow the path of least resistance. The abscess collects in whichever anatomic space the gland terminates, or wherever the path of least resistance

Classification

Anorectal abscesses are classified based on their location. Four types of anorectal abscesses are commonly described: perianal (superficial), ischiorectal (perirectal), intersphincteric, and supralevator. Perianal is the most common type and is the simplest to treat. The collections are located in the superficial perianal tissues and are typically located close to the anal verge. Ischiorectal abscesses are located more deeply in the ischiorectal fossa and may communicate to the contralateral

Treatment

The treatment of anal fistula is dictated by the classification and the amount of sphincter complex that is involved with the tract. Simple fistulas, intersphincteric, and low trans-sphincteric of cryptoglandular origin, can be treated easily with a fistulotomy with minimal risk to continence. Complex fistulas, high fistulas, and those related to inflammatory bowel disease must be treated through more intricate methods. The primary surgical approach to successful resolution of an anal fistula

Medical management

The major morbidity associated with the surgical treatment of fistula-in-ano is fecal incontinence. Kim and colleagues9 retrospectively studied 404 male patients with fecal incontinence and found that in patients younger than 70 years, the second most common association was a prior surgical fistulotomy or hemorrhoidectomy. Lindsey and colleagues10 performed anal manometry and endoanal ultrasonography in 93 patients being evaluated for fecal incontinence after anal surgery. They had universal

Preoperative planning

Simple submucosal, intersphincteric, and low trans-sphincteric fistulas are effectively managed by fistulotomy with minimal risk to fecal continence. In the past, the patient had to undergo an examination under anesthesia to determine the type of fistula and the amount of sphincter mechanism that was involved. If a simple fistula was found, then definitive management was typically undertaken. Complex fistulas would be managed through staged approaches. These decisions hinge on the clinician's

Fibrin glue

Because traditional methods to repair complex fistulas, including fistulectomies, fistulotomies, and advancement flaps, have resulted in high rates of incontinence, investigations into less invasive procedures have been performed. Fibrin glue first made its appearance in surgery during World War I, when it was used for hemostasis, and then later in the 1940s as a sealant for skin-graft procedures.24 In 1992, Hjortrup and colleagues25 first used it as a sealant for anal fistulas and since that

Fistula plug

Fibrin glue studies failed to achieve results that were reproducible, but did show promise in muscle-sparing, noninvasive operative techniques for anal fistulas. This result led to the development of additional sphincter-sparing therapies. The concept of a plug was first introduced in 2006 by Robb and colleagues40 and Johnson and colleagues41 with the idea that securing the plug into the primary opening of a fistula tract could close the tract more reliably than previous procedures, without

Advancement flap

Before the advent of the collagen anal fistula plug or the use of fibrin glue, surgeons devised the endorectal/endoanal advancement flap as a sphincter-sparing method to treat complex anal fistulas. It was believed that this would preserve continence because there is no surgical division of the anal sphincter complex. There are several methods, but the technical aspects common to all methods are cleaning/debridement of the fistula tract, mobilization of a well-vascularized rectal mucosal or

Setons

Setons are a viable treatment option for high trans-sphincteric fistulas, fistulas involving greater than half the bulk of the sphincter complex, and anterior trans-sphincteric fistulas in women. Setons are preferred to surgical fistulotomy because of the high incontinence rate associated with that technique in these patient populations.67, 68 The risk of and concern about incontinence are not eliminated with the use of cutting/tight setons. More conservative sphincter-sparing measures that do

Fistulotomy

Fistulotomy is still considered the standard by many surgeons for low, simple anal fistulas, such as submucosal, intersphincteric, and low trans-sphincteric fistulas (Fig. 7).67, 79 According to ‘The practice parameters for the treatment of perianal abscess and fistula-in-ano,’ completed by Whiteford and colleagues79 in 2005, fistulotomies may be used to treat simple anal fistulas in cryptoglandular disease and simple, low Crohn's fistulas that are symptomatic. Their definition of simple

Newer methods of treatment

The search for the optimal treatment of anal fistula continues because of disappointing success rates with sphincter-sparing options and high incontinence rates associated with sphincter dividing procedures. The ligation of the intersphincteric fistula tract (LIFT) procedure was first described in Thailand by Rojanasakul.88 This is a procedure in which a small incision is made in the intersphincteric groove (much like an open internal sphincterotomy) just over where the fistula tract crosses

Summary

The surgical management of fistula-in-ano is driven by the amount of sphincter complex that is involved with the tract, and the potential coexistence of Crohn's disease. The preferred method of management is dictated by these factors. Sphincter-sparing methods have lower success rates than nonsphincter-sparing techniques, but come with little to no risk of fecal continence. The first line of treatment of this disease should focus on methods that do not require any sphincter division. These

First page preview

First page preview
Click to open first page preview

References (91)

  • M.A. Abbas et al.

    Long-term outcome of endorectal advancement flap for complex anorectal fistulae

    Am Surg

    (2008)
  • A. Hamadani et al.

    Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess?

    Dis Colon Rectum

    (2009)
  • H. Ortiz et al.

    Length of follow-up after fistulotomy and fistulectomy associated with endorectal advancement flap repair for fistula in ano

    Br J Surg

    (2008)
  • I. Oliver et al.

    Randomized clinical trial comparing simple drainage of anorectal abscess with and without fistula tract treatment

    Int J Colorectal Dis

    (2003)
  • H.M. Quah et al.

    Meta-analysis of randomized clinical trials comparing drainage alone vs primary sphincter-cutting procedures for anorectal abscess-fistula

    Int J Colorectal Dis

    (2006)
  • A. Aluwihar

    Finding the source of a fistula

    Colorectal Dis

    (2005)
  • Y. Erhan et al.

    A case of large mucinous adenocarcinoma arising in a long-standing fistula-in-ano

    Dig Surg

    (2003)
  • T. Kim et al.

    Faecal incontinence in male patients

    Colorectal Dis

    (2008)
  • I. Lindsey et al.

    Patterns of fecal incontinence after anal surgery

    Dis Colon Rectum

    (2004)
  • L. Halme et al.

    Factors related to frequency, type and outcome of anal fistulas in Crohn's disease

    Dis Colon Rectum

    (1995)
  • J. Jakobovits et al.

    Metronidazole therapy for Crohn's disease and associated fistulae

    Am J Gastroenterol

    (1984)
  • E.E. Stringer et al.

    Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease

    Dis Colon Rectum

    (2005)
  • Y.P. Sangwan et al.

    Perianal Crohn's disease: results of local surgical treatment

    Dis Colon Rectum

    (1996)
  • J. Faucheron et al.

    Long-term seton drainage for high anal fistulas in Crohn's disease – a sphincter-saving operation?

    Dis Colon Rectum

    (1996)
  • S.B. Hanaver et al.

    Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial

    Lancet

    (2002)
  • D.H. Present et al.

    Infliximab for the treatment of fistula in patients with Crohn's disease

    N Engl J Med

    (1999)
  • B.E. Sands et al.

    Infliximab maintenance for fistulizing Crohn's disease

    N Engl J Med

    (2004)
  • W.B. Gaertner et al.

    Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?

    Dis Colon Rectum

    (2007)
  • C. Gonzalez-Ruiz et al.

    Intraoperative physical diagnosis in the management of anal fistula

    Am Surg

    (2006)
  • C. Ratto et al.

    Endoanal ultrasound-guided surgery for anal fistula

    Endoscopy

    (2005)
  • G.N. Buchanan et al.

    Potential clinical implications of directions of a trans-sphincteric anal fistula track

    Br J Surg

    (2003)
  • M.T. Swinscoe et al.

    Fibrin glue for fistula-in-ano: the evidence reviewed

    Tech Coloproctol

    (2005)
  • A. Hjortrup et al.

    Fibrin adhesive in the treatment of perineal fistulas

    Dis Colon Rectum

    (1991)
  • T.M. Hammond et al.

    Fibrin glue in the management of anal fistulae

    Colorectal Dis

    (2004)
  • V. de Parades et al.

    Seton drainage and fibrin glue injection for complex anal fistulas

    Colorectal dis

    (2008)
  • R.D. Ritchie et al.

    Incontinence rates after cutting seton treatment for anal fistula

    Colorectal Dis

    (2008)
  • J.R. Cintron et al.

    Repair of fistula-in-ano using fibrin adhesive. Long-term follow up

    Dis Colon Rectum

    (2000)
  • S.S. Gisbertz et al.

    Treatment of fistulas in ano with fibrin glue

    Dig Surg

    (2005)
  • G. Maralcan et al.

    The use of fibrin glue in the treatment of fistula-in-ano: a prospective study

    Surg Today

    (2006)
  • T. Adams et al.

    Long-term outlook after successful fibrin glue ablation of cryptoglandular transsphincteric fistula-in-ano

    Dis Colon Rectum

    (2008)
  • S.M. Sentovich

    Fibrin glue for anal fistulas: long-term results

    Dis Colon Rectum

    (2003)
  • I. Lindsey et al.

    A randomized, controlled trial of fibrin glue vs conventional treatment for anal fistula

    Dis Colon Rectum

    (2002)
  • O. Zmora et al.

    Prospective, multicenter evaluation of highly concentrated fibrin glue in the treatment of complex cryptogenic perianal fistulas

    Dis Colon Rectum

    (2005)
  • L. Patrlj et al.

    Fibrin glue-antibiotic mixture in the treatment of anal fistulae: experience with 69 cases

    Dig Surg

    (2000)
  • M.E. Witte et al.

    Fibrin glue treatment for simple and complex anal fistulas

    Hepatogastroenterology

    (2007)
  • Cited by (89)

    • New innovations in anal fistula surgery

      2019, Seminars in Colon and Rectal Surgery
    • Antibiotic use in prevention of anal fistulas following incision and drainage of anorectal abscesses: A systematic review and meta-analysis

      2019, American Journal of Surgery
      Citation Excerpt :

      In his landmark 1961 paper, Parks described the modern pathogenesis, classification, and treatment of perianal suppurative disease.1 Parks' cryptoglandular theory identifies the source of anorectal abscesses as an acute blockage of anal glands with chronic obstruction predisposing to fistula formation.1,4,5 Treatment of anorectal abscesses continues to revolve around early surgical drainage and control of perianal sepsis.4–6

    • Anorectal abscess and fistula

      2019, Anorectal Disorders: Diagnosis and Non-Surgical Treatments
    View all citing articles on Scopus
    View full text